Developing and using preparatory information for women undergoing radiation therapy for cervical or uterine cancer
- PMID: 11198902
Developing and using preparatory information for women undergoing radiation therapy for cervical or uterine cancer
Abstract
Purpose/objectives: To describe symptoms associated with radiation therapy necessary to develop preparatory concrete, objective information for women with cervical or uterine cancer.
Design: Prospective, descriptive.
Setting: University-affiliated radiation oncology department in the mid-south.
Sample: 49 of 52 women undergoing external beam radiation and low-dose rate brachytherapy for cervical or uterine cancer. Stage of disease ranged from I-IIIA. Mean age of subjects was 54 years; mean years of education was 11.
Methods: Investigator-developed symptom checklist based on prior research.
Main research variables: Symptom reports.
Findings: At least 40% of the women reported difficulty sleeping, fatigue, diarrhea, anorexia, nausea, urinary frequency, dysuria, vaginal discharge, and perineal irritation. Incidence and timing of symptoms varied by operative status and brachytherapy timing.
Conclusions: Findings confirm and clarify the symptoms women associate with radiation treatment for cervical or uterine cancer.
Implications for nursing practice: Assessing research findings for relevance to the care of patients in specific settings is necessary. These findings are appropriate for developing preparatory information for women undergoing external beam radiation and low-dose rate brachytherapy.
Similar articles
-
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71. doi: 10.1016/j.ijrobp.2004.11.041. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168838
-
The experience of women receiving brachytherapy for gynecologic cancer.Oncol Nurs Forum. 2001 May;28(4):743-51. Oncol Nurs Forum. 2001. PMID: 11383187
-
Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.Gynecol Oncol. 2006 Oct;103(1):94-9. doi: 10.1016/j.ygyno.2006.01.048. Epub 2006 Mar 9. Gynecol Oncol. 2006. PMID: 16527337
-
Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.J Urol. 2005 Mar;173(3):808-12. doi: 10.1097/01.ju.0000152698.20487.0e. J Urol. 2005. PMID: 15711274 Review.
-
[Indications for radiotherapy in cervical and uterine cancer following operation].Gynakologe. 1987 Dec;20(4):222-7. Gynakologe. 1987. PMID: 3325372 Review. German. No abstract available.
Cited by
-
Exploring a link between fatigue and intestinal injury during pelvic radiotherapy.Oncologist. 2010;15(9):1009-15. doi: 10.1634/theoncologist.2010-0097. Epub 2010 Jul 28. Oncologist. 2010. PMID: 20667967 Free PMC article.
-
Endometrial cancer survivors' sleep patterns before and after a physical activity intervention: A retrospective cohort analysis.Gynecol Oncol. 2018 Apr;149(1):133-139. doi: 10.1016/j.ygyno.2018.01.028. Epub 2018 Feb 1. Gynecol Oncol. 2018. PMID: 29395314 Free PMC article.
-
A cross-sectional study of obstructive sleep apnea in patients with colorectal cancer.J Gastrointest Oncol. 2022 Apr;13(2):683-694. doi: 10.21037/jgo-22-175. J Gastrointest Oncol. 2022. PMID: 35557570 Free PMC article.
-
Association between sleep quality and life satisfaction and self-efficacy among women with gynecological cancer in West China: A cross-sectional study.Support Care Cancer. 2025 Jul 11;33(8):679. doi: 10.1007/s00520-025-09734-w. Support Care Cancer. 2025. PMID: 40640428
-
Measurements and status of sleep quality in patients with cancers.Support Care Cancer. 2018 Feb;26(2):405-414. doi: 10.1007/s00520-017-3927-x. Epub 2017 Oct 23. Support Care Cancer. 2018. PMID: 29058128 Review.